Cellectis Correlations

CLLS Stock  USD 1.87  0.01  0.54%   
The current 90-days correlation between Cellectis SA and Eliem Therapeutics is 0.02 (i.e., Significant diversification). The correlation of Cellectis is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Cellectis Correlation With Market

Average diversification

The correlation between Cellectis SA and DJI is 0.16 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Cellectis SA and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cellectis SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Moving together with Cellectis Stock

  0.66ME 23Andme HoldingPairCorr
  0.76VALN Valneva SE ADRPairCorr
  0.61JNJ Johnson Johnson Sell-off TrendPairCorr
  0.82MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.73IPSC Century TherapeuticsPairCorr
  0.78MTEM Molecular TemplatesPairCorr
  0.86NKTX Nkarta IncPairCorr
  0.73TPST Tempest TherapeuticsPairCorr
  0.75AGL agilon healthPairCorr
  0.68BACK IMAC HoldingsPairCorr
  0.74CYRX CryoportPairCorr
  0.69SHG Shinhan FinancialPairCorr
  0.62VFSWW VinFast AutoPairCorr
  0.88EC Ecopetrol SA ADRPairCorr
  0.67HYMTF Hyundai MotorPairCorr
  0.67TLK Telkom Indonesia TbkPairCorr

Moving against Cellectis Stock

  0.78KZR Kezar Life SciencesPairCorr
  0.75MLYS Mineralys Therapeutics,PairCorr
  0.31MDGL Madrigal PharmaceuticalsPairCorr
  0.86AA Alcoa Corp Fiscal Year End 15th of January 2025 PairCorr
  0.8CAT Caterpillar Fiscal Year End 3rd of February 2025 PairCorr
  0.77T ATT Inc Aggressive PushPairCorr
  0.75HD Home DepotPairCorr
  0.74HPQ HP IncPairCorr
  0.73INTC Intel Fiscal Year End 23rd of January 2025 PairCorr
  0.69CVX Chevron Corp Fiscal Year End 7th of February 2025 PairCorr
  0.65BAC Bank of America Fiscal Year End 10th of January 2025 PairCorr
  0.58KB KB Financial GroupPairCorr
  0.55JPM JPMorgan Chase Fiscal Year End 10th of January 2025 PairCorr
  0.46MCD McDonalds Fiscal Year End 3rd of February 2025 PairCorr
  0.45IBM International Business Fiscal Year End 22nd of January 2025 PairCorr
  0.36VFS VinFast Auto Earnings Call TomorrowPairCorr
  0.36GE GE Aerospace Fiscal Year End 28th of January 2025 PairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
SCPHELYM
MCRBELYM
MCRBSCPH
LUMOMIST
MCRBHCWB
MISTHCWB
  
High negative correlations   
LUMOELYM
LUMOMCRB
LUMOSCPH
MISTSCPH
MISTELYM
MCRBMIST

Risk-Adjusted Indicators

There is a big difference between Cellectis Stock performing well and Cellectis Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cellectis' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Cellectis Corporate Management

MarieBleuenn TerrierGeneral Counsel, Member of the Executive CommitteeProfile
Dr MBAChief OfficerProfile
Valerie CrosPrincipal OfficerProfile
Kyung NamWortmanExecutive OfficerProfile
Philippe DuchateauChief Scientific OfficerProfile